RAINBOW · Health Care · 2026-08-28

Rainbow Children's Medicare Ltd

4.4WatchSolid +1.2Stage 2 · wk 11In scan: Pullback Hunter · Prop Scan · Breakout WatchMARKET: WEAK RECOVERING · 2026-08-28
₹1,442.8
+0.12% today
₹14,637 Cr · Mid cap
About this companyHealth Care· Hospitals & Diagnostic Centres
Expand ▾

Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.

Visit company website →
P/E (TTM)
50.2
Forward 36.0
Earnings Growth (YoY)
+5.6%
Revenue +11.9%
Dividend Yield
0.22%
P/B 9.2
vs 52W High
-9.7%
₹1,103.8 lo₹1,598.6 hi
9.7% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 11
1w13w26w
Week 11 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is typically 13–26 weeks — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
9.1%
200 DMA: ₹1,323 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.71x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -1.2% vs MA50 +3.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Health Care
↓ Peaking
Stage 2%
48.9%
20d Δ
-3.4pp
1M return
+3.0%
3M return
+13.6%
Sector Stage-2 % · last 20 days
This stock ranks #69 of 84 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
41.9%
20d Δ
-17.3pp
1M return
-2.7%
3M return
+7.0%
Industry Stage-2 % · last 20 days
Ranks #12 of 13 Stage 2 stocks in this industry.
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-06-02 → 2026-08-28
S2 18w
S2 32w
S2 17w
S4 25w
2023-06-022026-08-28
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 18w → S3 4w → S2 1w → S3 2w → S2 32w → S3 7w → S4 4w → S1 1w → S2 17w → S3 6w → S4 6w → S1 11w → S2 9w → S3 6w → S4 25w → S1 8w → S2 10w current
Total tracked: 167 weeks across 17 stage runs.
1M
-5.1%
3M
+5.3%
6M
+18.5%
YTD
+6.2%
1Y
-8.7%
Scan Membership
Pullback Hunter
Latest: 2026-08-17
Prop Scan
Latest: 2026-08-17
Breakout Watch
Latest: 2026-06-17
29 appearances in last 60 days. First seen: 2024-10-01.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-28S2
Wk 11 · Vol —x
2026-08-27S2
Wk 11 · Vol —x
2026-08-26S2
Wk 11 · Vol —x
2026-08-25S2
Wk 10 · Vol —x
2026-08-24S2
Wk 10 · Vol —x
2026-08-21S2
Wk 10 · Vol —x
2026-08-20S2
Wk 10 · Vol —x
2026-08-19S2
Wk 9 · Vol —x
2026-08-18S2
Wk 9 · Vol —x
2026-08-17S2
Wk 9 · Vol —x
2026-08-14S2
Wk 9 · Vol —x
2026-08-13S2
Wk 9 · Vol —x
Sector Peers — Stage 2All →
MARKSANS
wk 15 · -1.0% from hi
9.8
BLISSGVS
wk 39 · 0.0% from hi
9.4
ENTERO
wk 3 · 0.0% from hi
9.2
GLAND
wk 14 · -2.8% from hi
8.8
ALBERTDAVD
wk 1 · 0.0% from hi
8.7
Moving averages & range
50 DMA
₹1,474.6
200 DMA
₹1,323
52W High
₹1,598.6
52W Low
₹1,103.8
5D Low
₹1,441
Resistance levels (recent highs)
20d High
₹1,598.6
60d High
₹1,598.6
120d High
₹1,598.6
250d High
₹1,598.6
Next resistance
+10.8%
to 20d High

All analytics based on EOD data. Data as of 2026-08-28. Past data patterns are not indicative of future results. This page is a data analytics tool only.